Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Amlodipine Besylate prices in the United States rose 5.5% in Q2 2026 to USD 86,500.00/MT from USD 82,000.00/MT in Q1, holding above April 2026 levels as elevated crude oil prices kept energy and feedstock costs high for API manufacturers. Prices had fallen sharply in Q4 2025, down more than 7% in the US alone on ample Asian supply and weak seasonal demand, before reversing hard in Q1 2026 as Brent crude held above USD 110 per barrel. Globally, the average rose from USD 79,410.00/MT in Q1 to USD 83,430.00/MT in Q2, a 5.1% gain. For H2 2026, a global average of USD 78,000.00-92,000.00/MT is expected, with freight surcharges on Asian shipments and consistent hospital and retail pharmacy demand likely to keep this market elevated.
Amlodipine Besylate is a calcium channel blocker widely prescribed for hypertension and angina pectoris, making it one of the highest-volume active pharmaceutical ingredients in global cardiovascular medicine. It works by inhibiting calcium ion influx across cardiac and vascular smooth muscle cell membranes, producing arterial vasodilation and reducing myocardial oxygen demand. India and China are among the dominant global producers of this API, supplying both domestic formulators and export markets across North America and Europe. Precursor chemical and energy costs, freight and shipping-route conditions, hospital and retail pharmacy procurement cycles, and regional supply chain restructuring are what drive prices in this market.
The outlook for Amlodipine Besylate through H2 2026 stays elevated, carrying forward the cost pressures that have defined this market since the start of the year. Brent crude has held above USD 110 per barrel for an extended stretch, keeping energy and feedstock costs high for API manufacturers across India and China, while freight surcharges on shipments from Asia remain in effect as vessel rerouting continues extending delivery timelines beyond typical scheduling windows.
The main upside risk is a further escalation of Middle East shipping disruptions, which could extend elevated freight surcharges and feedstock costs further into the second half of the year. The main downside risk is a resolution of shipping-route tensions combined with excess Asian supply reasserting itself, which could pull prices back toward the softer levels seen in late 2025.
| Region | 2026 Price Range (USD/MT) | Outlook |
| Global Average | 78,000.00 - 92,000.00 | Elevated crude prices and freight surcharges keep this firm |
| United States | 83,000.00 - 96,000.00 | Hospital procurement absorbs elevated pricing without resistance |
| China | 80,000.00 - 92,000.00 | Large-scale API production keeps demand robust |
| Germany | 79,000.00 - 90,000.00 | Steady healthcare demand supports continued firmness |
| India | 77,000.00 - 89,000.00 | Export-oriented API production drives continued gains |
US Amlodipine Besylate prices averaged USD 86,500.00/MT in Q2 2026, the highest of any region tracked here, up 5.5% from USD 82,000.00/MT in Q1, holding above April 2026 levels as elevated crude oil prices kept feedstock costs high.
Why did the price of Amlodipine Besylate change in Q2 2026 in the United States?
Consistent demand from hospital procurement and retail pharmacy channels continued absorbing the elevated pricing without significant resistance, keeping the upward trajectory intact even as Brent crude held above USD 110 per barrel.
Chinese prices averaged USD 83,500.00/MT in Q2 2026, up 5.0% from USD 79,500.00/MT in Q1, as this dominant API production hub continued absorbing elevated energy and feedstock costs.
Why did the price of Amlodipine Besylate change in Q2 2026 in China?
Energy and feedstock costs for API manufacturers stayed elevated, and with freight surcharges on shipments from Asia remaining in effect, Chinese producers continued passing through a meaningful share of those costs to buyers.
German prices averaged USD 82,000.00/MT in Q2 2026, up 4.5% from USD 78,500.00/MT in Q1, as steady healthcare sector demand kept this market on a firm upward path.
Why did the price of Amlodipine Besylate change in Q2 2026 in Germany?
Steady prescription growth continued underpinning demand even as supply chain restructuring and inventory management dynamics influenced the overall market outlook across the European healthcare sector.
Indian prices averaged USD 81,000.00/MT in Q2 2026, up 5.2% from USD 77,000.00/MT in Q1, as export-oriented API production continued supporting continued gains.
Why did the price of Amlodipine Besylate change in Q2 2026 in India?
Vessel rerouting continued extending delivery timelines beyond typical scheduling windows, adding to landed costs, while export demand from North American and European buyers kept Indian API producers running at firm utilization.
US prices surged 19.3% in Q1 2026 to USD 82,000.00/MT from USD 68,762.00/MT in Q4 2025, reversing a sharp late-2025 decline as elevated crude oil prices pushed feedstock costs higher.
Why did the price of Amlodipine Besylate change in Q1 2026 in the United States?
The global market experienced a mild downward pricing trend in the prior quarter, but tighter spot supply and cautious procurement strategies gave way to a sharp reversal as Brent crude climbed and freight surcharges on shipments from Asia took hold, with vessel rerouting extending delivery timelines and keeping energy and feedstock costs high for API manufacturers across India and China.
Chinese prices surged 13.9% in Q1 2026 to USD 79,500.00/MT from USD 69,800.00/MT in Q4 2025, tracking the broader global feedstock cost spike.
Why did the price of Amlodipine Besylate change in Q1 2026 in China?
Export restrictions, procurement adjustments, and rising raw material costs drove moderate fluctuations through the quarter, with regional pricing behavior across APAC highlighting the influence of supply chain restructuring and inventory management on the overall market outlook.
German prices surged 14.2% in Q1 2026 to USD 78,500.00/MT from USD 68,755.00/MT in Q4 2025, reversing the ample-import-driven decline seen in the prior quarter.
Why did the price of Amlodipine Besylate change in Q1 2026 in Germany?
Ample imports and weak demand had pressured prices lower in the prior quarter, but that trend reversed sharply as elevated crude oil prices and freight surcharges from Asian shipping routes pushed feedstock costs up across the value chain.
Indian prices surged 14.1% in Q1 2026 to USD 77,000.00/MT from USD 67,500.00/MT in Q4 2025, tracking rising energy and feedstock costs for domestic API manufacturers.
Why did the price of Amlodipine Besylate change in Q1 2026 in India?
Rising raw material costs, logistics developments tied to vessel rerouting around the Strait of Hormuz, and changing pharmaceutical demand patterns combined to push Indian API prices up sharply through the quarter.
Global Amlodipine Besylate prices moved gradually through most of 2025 before declining sharply in Q4 on ample Asian supply and weak seasonal demand, then reversed dramatically in Q1 2026 as elevated crude oil prices and Middle East-linked freight surcharges pushed feedstock costs for API manufacturers sharply higher, a trend that continued into Q2.
| Quarter | Price (USD/MT) | QoQ Change | Direction |
| Q2 2026 | 83,430.00 | +5.1% | ↑ Rising |
| Q1 2026 | 79,410.00 | +15.5% | ↑ Rising |
| Q4 2025 | 68,752.56 | -4.8% | ↓ Falling |
| Q3 2025 | 72,240.00 | +0.5% | ↑ Rising |
| Q2 2025 | 71,845.80 | - | — Stable |
| Q3 2026 | In Progress | - | — In Progress |
Amlodipine Besylate prices declined modestly across every market covered in this report through 2025, as ample Asian supply and cautious procurement weighed on the market for much of the year, particularly in the fourth quarter, before elevated crude oil prices and Middle East-linked freight disruptions reversed the trend sharply in early 2026.
US prices declined from about USD 76,440.00/MT in Q1 2025 to USD 68,762.00/MT by Q4, down roughly 10.0%, the steepest annual decline of the four regions, before the sharp Q1 2026 reversal that followed.
Chinese prices declined from about USD 72,411.00/MT in Q1 2025 to USD 69,800.00/MT by Q4, down roughly 3.6%, tracking large-scale production and steady pharmaceutical consumption through the year.
German prices declined from about USD 71,000.00/MT in Q1 2025 to USD 68,755.00/MT by Q4, down roughly 3.2%, the smallest annual decline of the four regions.
Indian prices declined from about USD 70,000.00/MT in Q1 2025 to USD 67,500.00/MT by Q4, down roughly 3.6%, tracking the broader global softening before the sharp 2026 reversal began.
Expert Market Research: Your Source for Real-Time Amlodipine Besylate Price Intelligence
Expert Market Research tracks Amlodipine Besylate prices continuously across every major producing and consuming region, combining precursor chemical and energy cost data, freight and shipping-route condition trends, and hospital and retail pharmacy demand signals into a single, regularly updated view of the market. Our team can help your procurement function benchmark current offers, plan purchases around the crude-driven volatility covered in this report, and build a defensible view of where this widely used cardiovascular API is headed next. Reach out to our team for a tailored briefing or a deeper look at any of the regional markets covered here.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It is a calcium channel blocker widely prescribed for hypertension and angina pectoris, making it one of the highest-volume active pharmaceutical ingredients in global cardiovascular medicine.
The Q2 2026 global average was USD 83,430.00/MT, ranging from USD 81,000.00/MT in India to USD 86,500.00/MT in the United States.
The global average rose from USD 68,752.56/MT in Q4 2025 to USD 79,410.00/MT in Q1 2026, a 15.5% surge, and then to USD 83,430.00/MT in Q2, as elevated crude oil prices and freight surcharges kept feedstock costs high.
Brent crude climbed and held above USD 110 per barrel following Middle East shipping disruptions, and freight surcharges on shipments from Asia, driven by vessel rerouting, pushed energy and feedstock costs sharply higher for API manufacturers across India and China after a soft Q4 2025 dominated by ample Asian supply.
The global average is expected in the USD 78,000.00-92,000.00/MT range, with elevated crude prices and freight surcharges likely to keep this market firm.
India holds the lowest cost among the regions tracked here, while the United States carries the highest cost given strong hospital and retail pharmacy demand absorbing elevated pricing.
This report is updated monthly. For real-time pricing intelligence, connect with the Expert Market Research team.
Precursor chemical and energy costs, freight and shipping-route conditions, hospital and retail pharmacy procurement cycles, and regional supply chain restructuring.
India and China are among the dominant global producers of this active pharmaceutical ingredient, supplying both domestic formulators and export markets across North America and Europe.
Buyers can monitor crude oil prices and Asian freight surcharge trends given their outsized influence on this market, time forward purchases around the quarterly breakdowns in this report, and benchmark supplier quotes against the tracked price ranges.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.